Shenzhen Mlife Technology Co., Ltd.

Email:sales@mlifevapor.com
WhatsApp:+86 13871529372

FDA issues warning letters to three e-cigarette distributors

Time: 2023-07-29

Views: 449

The U.S. Food and Drug Administration (FDA) issued warning letters to three distributors, namely ABS Distribution Inc., EC Supply, Inc. and Easy Wholesale, LLC. The reason is that they sell and/or distribute a variety of unauthorized vaping products.

On July 27, the US Food and Drug Administration (FDA) issued warning letters to three distributors, namely ABS Distribution Inc., EC Supply, Inc. and Easy Wholesale, LLC. The reason given by the FDA is that they sell and/or distribute a variety of unauthorized vaping products. These illegal products include Elf Bar/EB Design, Esco Bars and Puff Max, popular e-cigarette products popular among young people.


 


In this regard, Two Supremes got in touch with the responsible department of Ai Miracle after learning of the news. Ai Miracle said:


 


"I have learned about the actions taken by the FDA on July 27. Love Miracle understands that our US e-cigarette distributors insist on providing responsibly produced, high-quality products to retail customers while following the law. At the same time, Love Miracle We remain supportive of our distribution and commercial partners and work with regulators to resolve these issues."


 


FDA steps up regulation

 


Dr. Brian King (Brian King), director of the FDA Center for Tobacco Products (CTP), said that the FDA is committed to keeping a close eye on the rapidly developing e-cigarette industry, including quickly identifying products that are popular with young people through various scientific means.


 


"We will continue to take a data-driven approach and take action across the supply chain, including the distribution of illegal products between manufacturers and points of sale."


 


The distributor involved is suspected of violating the regulations

 


The distributors who received the warning letters sold and/or distributed vaping products in the United States that were not authorized by the FDA, which is prohibited under the Federal Food, Drug, and Cosmetic Act.


 


All of the brands listed in these warning letters were identified as the most popular vaping products among young Americans.


 


The warning letter is part of a series of measures the FDA has taken in all aspects of the supply chain to deal with these brands that are popular with young people. Other recent actions include:


 


Warning letter issued to company responsible for Esco Bars

Warning letter to retailers and distributors about Puff products

Warning letter to retailers regarding Elf Bar/EB Design and Esco Bars products

Import warning issued for all Elf Bar/EB Design and Esco Bars products

 


Ann Simoneau, director of the FDA Office of Compliance and Enforcement, said:


 


"Warning letters are usually the first step after an inspection uncovers violations. We will monitor to ensure these violations are corrected, and if not corrected in a timely manner, the recipient will face further action such as civil fines, seizures and injunctions."


 


For voluntary compliance, companies receiving a warning letter have 15 business days to respond to the actions they will take to correct the violation and prevent future violations. Most companies that received warning letters took corrective action voluntarily. However, failure to correct violations in a timely manner may result in additional FDA action such as injunctions, seizures, and/or civil monetary penalties.


 


Over the past year, the FDA has issued its first injunctions and civil fines against e-cigarette makers. The agency intends to make these actions a regular part of its enforcement mix; for example, since January 2023, the agency has issued civil fines to 15 manufacturers for illegally selling e-cigarettes.


 


Improving FDA's own regulatory capabilities

 


In addition to taking action against illicit products throughout the supply chain, the FDA said it will continue to evaluate and enhance its surveillance capabilities to best monitor the changing tobacco product marketplace. For example, the FDA and the National Institutes of Health last month announced funding for a new Tobacco Rapid Surveillance Center. The Center of Expertise will complement the Tobacco Products Center's internal monitoring efforts, providing additional rapid information for monitoring changes in tobacco product markets and smoking patterns.



Email:sales@mlifevapor.com

WhatsApp:+86 13871529372

Email:sales@mlifevapor.com

WhatsApp:+86 13871529372


Tel:+86 13871529372

Add:6 / F, block B, building 2, Fuyong Tongtai times center, Bao'an District, Shenzhen

Copyright © 2008-2022 Shenzhen Mlife Technology Co., Ltd. All Rights Reserved

Language: 简体中文  | >

Copyright © 2008-2022 Shenzhen Mlife Technology Co., Ltd. All Rights Reserved

Tel:+86 13871529372

Add:6 / F, block B, building 2, Fuyong Tongtai times center, Bao'an District, Shenzhen    Website